Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Passive investing can simplify retirement saving by lowering costs and smoothing returns. Learn why this approach often suits long-term goals vs active strategies.
23,287 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Energy Transfer has kicked off the year with impressive momentum and a raised outlook. This article breaks down why t...
SpaceX lit up the market with a big debut, yet the price tag raised serious questions. This article breaks down why m...
Starting with $1,000, you can anchor a tech-forward portfolio on three core players. This guide explains why these co...
When biotech headlines hit, stocks can swing quickly. Here’s a grounded look at why stock skyrocketed today for Q32 B...
At the dawn of 2026, rental demand isn’t following the usual big-city script. Cities like Cincinnati, Atlanta, and Mi...
In uncertain times, one reliable approach is to target recession-resistant dividend stocks. This article shines a lig...
As tensions flare, Qatar’s plan to buy $4 billion in Patriot missiles reshapes security and markets. This article bre...
As June approaches, analysts watching closely into June are assessing AI ETF trends, liquidity, and risk. This guide ...
Wall Street’s bearish take on Plug Power stock has critics unsure. This article builds a practical bull case, showing...